• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于卫生政策决策的健康经济模型可信度的证据:对腹主动脉瘤筛查的系统文献回顾。

Evidence for the credibility of health economic models for health policy decision-making: a systematic literature review of screening for abdominal aortic aneurysms.

机构信息

Centre for Health Service Research and Technology Assessment, University of Southern Denmark, Odense, Denmark.

出版信息

J Health Serv Res Policy. 2012 Jan;17(1):44-52. doi: 10.1258/jhsrp.2011.010133. Epub 2011 Sep 27.

DOI:10.1258/jhsrp.2011.010133
PMID:21954237
Abstract

OBJECTIVE

To investigate whether the credibility of health economic models of screening for abdominal aortic aneurysms for health policy decision-making has improved since 2005 when a systematic review by Campbell et al. concluded that reporting standards were poor and there was divergence between the findings of studies that was hard to explain.

METHODS

A systematic literature review was carried out following PRISMA reporting principles. Health economic models of the cost-effectiveness of screening for abdominal aortic aneurysms published between 2005-2010 were included. Key characteristics were extracted and the models were assessed for quality against guidelines for best practice by a multidisciplinary team.

RESULTS

Seven models were identified and found to provide divergent guidance. Only three reports met 10 of the 15 quality criteria.

CONCLUSIONS

Researchers in the field seem to have benefited from general advances in health economic modelling and some improvements in reporting were noted. However, the low level of agreement between studies in model structures and assumptions, and difficulty in justifying these (convergent validity), remain a threat to the credibility of health economic models. Decision-makers should not accept the results of a modelling study if the methods are not fully transparent and justified. Modellers should, whenever relevant, supplement a primary report of results with a technical report detailing and discussing the methodological choices made.

摘要

目的

调查自 2005 年坎贝尔等人的系统评价得出报告标准较差且难以解释研究结果之间存在分歧的结论以来,针对腹部主动脉瘤筛查的卫生经济学模型是否在为卫生政策决策提供可信度方面有所改善。

方法

按照 PRISMA 报告原则进行系统文献回顾。纳入了 2005 年至 2010 年间发表的关于筛查腹部主动脉瘤的成本效益的卫生经济学模型。由多学科团队根据最佳实践指南提取关键特征并评估模型质量。

结果

确定了 7 个模型,发现它们提供了不同的指导。只有三份报告符合 15 项质量标准中的 10 项。

结论

该领域的研究人员似乎受益于卫生经济建模的普遍进步,并且注意到报告方面的一些改进。然而,模型结构和假设方面研究之间的低一致性以及难以证明这些假设的合理性(收敛有效性)仍然对卫生经济学模型的可信度构成威胁。如果方法不透明且合理,决策者不应接受建模研究的结果。建模者应在相关情况下,用详细说明和讨论所做方法选择的技术报告补充主要结果报告。

相似文献

1
Evidence for the credibility of health economic models for health policy decision-making: a systematic literature review of screening for abdominal aortic aneurysms.用于卫生政策决策的健康经济模型可信度的证据:对腹主动脉瘤筛查的系统文献回顾。
J Health Serv Res Policy. 2012 Jan;17(1):44-52. doi: 10.1258/jhsrp.2011.010133. Epub 2011 Sep 27.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
7
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.血管内支架治疗腹主动脉瘤:系统评价和经济模型。
Health Technol Assess. 2009 Oct;13(48):1-189, 215-318, iii. doi: 10.3310/hta13480.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

引用本文的文献

1
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge.阿尔茨海默病和相关痴呆症的成本效益模型:IPECAD 建模研讨会交叉比较挑战。
Alzheimers Dement. 2023 May;19(5):1800-1820. doi: 10.1002/alz.12811. Epub 2022 Oct 25.
2
Cost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort using a decision analytical model.现代背景下男性腹主动脉瘤筛查与再筛查的成本效益:使用决策分析模型对假设队列的评估
BMJ. 2012 Jul 5;345:e4276. doi: 10.1136/bmj.e4276.